Literature DB >> 2126320

Secretion of plasminogen activator inhibitor by normal rat pleural leukocytes in culture.

X Y Li1, G M Brown, D Lamb, K Donaldson.   

Abstract

The normal balance between coagulation and fibrinolysis in the pleural cavity is poorly understood despite the critical role of the pleura in the movement of the lungs. To determine the fibrinolytic activity and the interaction between plasminogen activators and their inhibitors in the normal pleural space, we tested normal rat pleural leukocytes, principally macrophages and mast cells, and their supernatants, for activity in an [125I]fibrin degradation assay. It was found that pleural leukocytes did not release plasminogen activator, but the leukocytes and their supernatants inhibited the plasminogen-dependent fibrinolysis caused by both alveolar leukocytes and mesothelial cells. Further experiments demonstrated that pleural leukocytes produce a protein inhibitor primarily against urokinase-induced fibrinolysis in culture and that macrophages are the main source of the inhibitor. The lysate of mast cell-enriched population exhibited high plasminogen activator activity while no such activity could be determined in macrophage-enriched lysate. These data show that normal rat pleural leukocytes contain plasminogen activator inside the cells and synthesize a urokinase-type plasminogen activator inhibitor in culture that may be important in the fibrinolysis/coagulation balance in the pleural space.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126320     DOI: 10.1007/bf02719708

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  24 in total

1.  Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.

Authors:  E G Levin
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

2.  Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.

Authors:  H A Chapman; O L Stone
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

3.  Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.

Authors:  S Idell; B T Peterson; K K Gonzalez; L D Gray; R Bach; J McLarty; D S Fair
Journal:  Am Rev Respir Dis       Date:  1988-11

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages.

Authors:  H A Chapman; J J Reilly; L Kobzik
Journal:  Am Rev Respir Dis       Date:  1988-02

6.  The mesothelium: its fibrinolytic properties.

Authors:  D Whitaker; J M Papadimitriou; M Walters
Journal:  J Pathol       Date:  1982-04       Impact factor: 7.996

7.  Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.

Authors:  J H Verheijen; D C Rijken; G T Chang; F E Preston; C Kluft
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

8.  Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.

Authors:  M Philips; A G Juul; S Thorsen
Journal:  Biochim Biophys Acta       Date:  1984-11-06

9.  Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.

Authors:  Q Dong; M H Zhou; V Subbarao; C H Ts'ao
Journal:  Br J Exp Pathol       Date:  1988-10

10.  Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.

Authors:  B W Robinson
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.